https://scholars.lib.ntu.edu.tw/handle/123456789/560007
標題: | Long-term Outcome of Endovascular Treatment for Mycotic Aortic Aneurysm | 作者: | Luo C.-M. CHIH-YANG CHAN YIH-SHARNG CHEN SHOEI-SHEN WANG NAI-HSIN CHI I-HUI WU |
公開日期: | 2017 | 出版社: | W.B. Saunders Ltd | 卷: | 54 | 期: | 4 | 起(迄)頁: | 464-471 | 來源出版物: | European Journal of Vascular and Endovascular Surgery | 摘要: | Objective/Background Endovascular repair (EVAR) of mycotic aortic aneurysm (MAA) has become an alternative treatment for high risk patients. The aim of this study was to evaluate long-term survival and outcomes. Methods Retrospective analysis of 40 consecutive patients with MAAs undergoing EVAR and subsequent intravenous antibiotic treatment between September 2009 and April 2015. Follow-up was truncated on 30 April 2015. Uni- and multivariate logistic regression were used to assess risk factors of adverse outcomes. Cumulative survival was calculated using the Kaplan–Meier method. Results Median age at repair was 73 years (range 48–88 years) and 31 (77%) were men. Eleven (27%) patients were infected with Salmonella, 12 (30%) with non-Salmonella species, and 17 (42%) had negative cultures. Anatomical locations included the aortic arch/thoracic area in 10 (25%), the paravisceral area in seven (17%), and the infrarenal area in 23 (57%). Ten (25%) patients presented with aneurysm rupture and underwent emergency repair. Median follow-up was 25 months (range 1–69 months). Cumulative 1 and 5 year survival rates were 71% and 53%, respectively. Persistent or recurrent infection occurred in 20% (n = 8). Patients with persistent infection were treated with long-term medical therapy, but all died (75%; n = 6) within 6 months of repair. No survival difference was found between patients with or without Salmonella infections. However, there was a trend toward better survival in culture negative patients. Conclusion EVAR of MAA is an acceptable alternative treatment of MAA. However, persistent infection after endovascular treatment does occur and is often fatal without surgical treatment. ? 2017 European Society for Vascular Surgery |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027582791&doi=10.1016%2fj.ejvs.2017.07.004&partnerID=40&md5=d729c15b395dee8a681d5f08d5a15b58 https://scholars.lib.ntu.edu.tw/handle/123456789/560007 |
ISSN: | 1078-5884 | DOI: | 10.1016/j.ejvs.2017.07.004 | SDG/關鍵字: | antibiotic agent; ceftriaxone; antiinfective agent; adult; aged; anatomic landmark; aneurysm rupture; antibiotic therapy; aortic aneurysm; aortic arch; Article; clinical article; clinical outcome; emergency surgery; endovascular aneurysm repair; female; follow up; human; Kaplan Meier method; long term care; long term survival; male; multivariate logistic regression analysis; mycotic aneurysm; persistent infection; priority journal; recurrent infection; retrospective study; risk factor; Salmonella; salmonellosis; survival rate; univariate analysis; endovascular surgery; infected aneurysm; microbiology; middle aged; mortality; thoracic aorta aneurysm; treatment outcome; very elderly; Aged; Aged, 80 and over; Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Thoracic; Endovascular Procedures; Female; Humans; Male; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。